Pressurl: https://news.google.com/rss/articles/CBMiggFBVV95cUxNUTc5YVFwVEV1cHdpVkVXcFBhdUZETG1oVnpteldJdF9rWmtRTFF3V1ZyT0pTS3FlWG13Ny10eWs2TTBEaHptdVJOOUdDWkRhb1FQSEVGeUxPMHhBY2FDYzJrT0M2OHZaclA2X1BiREF0ZGNqM3lrRjRoRmU0dFZiM2Fn?oc=5 · headline: Metis TechBio seals $1.62b global licensing deal with Boulevard Bio · publication: China Daily Global Editiongoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiygFBVV95cUxNc0wwZENjRHh3VXZwcWV4NG5Vd29ReDRmblhRZ214bDF2blVlbHYwSzFiRHhONHczTXhKZ0NNWGxDYUE3WWFKVWhBbVNLT24tdEROVUFRazRGcHAwQnJFN1pwZWJaUXMxcmZnaTJwMXVyd1VpWTlHTXpsd3NiNnRyRkpvX0lkN3ZsS0hqZmQ1bnQ1RjNpQVZTbnYwQVEwaE9TVlIwYjNFdjBZV3Z3VnVUS1JwZGpUVFd4enh5S2dOUll2MVBvbm9aTy13?oc=5 · headline: METiS TechBio licenses T-cell engager to Boulevard Bio in potential $1.62 billion deal · publication: The Pharma Lettergoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi4wFBVV95cUxOdUpFdjdDU3QzMVRyOEtTbmgtR0o1NVUyUUZBQ2xlLXE4d1R3YVpZdHJCc2k4OWhRaFhJN0FhZnpiZ3FwdEQ2eTlGQWI3NTJtN3hmQXNxb0NtQ0p1Y3d3LXNEZ0p1V29md0lnMmlDZTlqYWJxMkwxcGlGem1mTzRKdUlJcEF0NDM4MlNwb3pTTVhrMC1CUWhGT2xYdHRDOE5UUXRDU2RwLU9pWXdVM1N0ckZQMUFHc0d5b2lKMjFwYXRQcUpzaW94QmJDT2tZdmp2YkJyLWlEa1lqZFFHNHlaVW1sQQ?oc=5 · headline: METiS TechBio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager · publication: PR Newswiregoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiswFBVV95cUxOdlhhalJadDBUUTcyUExIUVF0b21YQTNJYjhQRWIteGdSWGpyS1ktT3RhcEtZYnFzZGc1QVB0TGk5dHA3X1pRbEJ3bDBFTk9LUGFyRXVxWnRpWkg2dGNCZ1hqdTNtSVVSYUJwTF9oazhHWnBuQVRzakZoV1VpVVgySkJyd3F5ekdrblYteDZyTDdRblV2ZmZjYm9HMWw0U3pvNHlPZUhnV3lhYjFGRVMzNHlUTQ?oc=5 · headline: Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE from China’s Metis TechBio · publication: Fierce Biotech
google_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMihgFBVV95cUxQOGlQVlNIVlRnc1MwbFhPSTVjOUdZYkhsVFJXLVFzNTl0TWxFUXNXdm13d0MwUTNtS3hTY3VFbURCVVo1MjQyY3NTdUppXzgtNUFheUFVcGxIYzB3SGhkV3o4c3BFc1hqYU9zRm5BalBJTlpaMWQ3M0FOZk1mempJNEp0R1R4QQ?oc=5 · headline: Eyes on Asia: Fosun, Insilico, Boulevard Bio · publication: bioxconomy.comgoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiuAJBVV95cUxNVU5WSi1lX1RVZE1GaEF4NWlsX1dNckJMaTdpLXRUUGF1eFFPOXhBYWNGbk1Ua3Z3bkxSRE1qTHBBZlZoVjRGNl9NNW8wUTVyb3gwLVZoWHJySnF0eWVrc1QySHRkU1dzWmdJQmpydmszYjV0RzZqcnpETURtNFpKdnQxQ2RaVFk5N1NWZWtrQjBPQm9mVllhSmhhdTdsR2FDVmJ4djd6OC15cFNNZzhsZ2h3QUdjX1ZnblozODdDOUtPLTVUNmJkOUp1cllaTGNBRzZPTHYxc1EzbllwR0tySmU5MmtQdXBGejdObUtCRnpyeUpFdHdSejk1VElpejdQNkUxUi1EZ2RWc3VyVmJXaGE5WTlQcGFoVFpGZzJBOFl6RGtLVE9rcVBvY0FmV1BoaUxzeE5Ndmw?oc=5 · headline: AlivaMab Biologics and Ablexis Congratulate Boulevard Bio on its Launch and the Ongoing Phase 1 Clinical Trial of Bispecific Antibody BLVD101 · publication: FinancialContentgoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMisAFBVV95cUxPT3ZHUG5RRnBhTlNtanZMSEdlQmo4OHlnSUUtQjg0X3FWV2VEMmVIalZocWJoMkdhc0xtcmFrdWdQSUU5ejhFaHRDeXA1blBBRDFCdWJaWUF5R0V2X1lvMWhKSzlQczRIVW1xaktYUXJOdFVlSDc5WlhxWXBPbHNRSlhUaFBxeVR5U01YQlhYbFFiV0VLOURkajhtTTlMVkthX0pnaWlrWXhmdm9vR0Z4dw?oc=5 · headline: Boulevard Bio Launches With $65M to Advance Precision Immunology Pipeline · publication: citybizgoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMinAFBVV95cUxONGtKQ1BhbWUxY3djbG5MTVFrdzh5VkxON1BIck1PN2lFMFF3c1RkdklFdVhHd1lYVzJ6X3V2QmcyaEhMM3BmQ2QyVTh0ay1zNEZyTGFBVEt5MzhKcUVMMkRENWF0Rk5BZ2FmMG1ScU1DZkt0eFFoTmVvLTM2VVRYUTdvcG54LS1qMFBud0hINWdiQk1QaTVpMkZPWHQ?oc=5 · headline: Boulevard Bio launches with $65M seed to chase autoimmune cures · publication: Dealroomgoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiiwFBVV95cUxNTzJ2Y3lfQkNjdThXT2F5SGlMWG9DS1I2N3VrWFpMeWRpTkhSMVZsSDM5bkFpaURsQl9LZDZIS2JKQnlScHBUOWp5V1JhNkZ6U180RXluSXRUOFQ4LWc3OTVJZ1JnSC12eDNqU2VDLS10dk93Y0N5cVVhX2JaVVVYbGh4ZEJVOHRzZS1r?oc=5 · headline: Boulevard starts up with $65M to pursue targeted autoimmune drugs · publication: BioPharma Divegoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiigFBVV95cUxON1VJVVBlY1BRQXd0VFljR1NENW5ib3lYb3FQSWc4SHRYTzIyd200Q0hYZGlnc0p4bnRXdkY0blFKS0hKbUZ6a1poSGxjOElKeFRqeUsybTZfb2tkVHFoNTdsRTRUU01UZWtpRzZoalFrU3lxNFJ1WmVCa050am1IZXYxa1ZMZmNpVUE?oc=5 · headline: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies · publication: STATgoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiigFBVV95cUxNMG1xbUJia0QySVFPV3JHV1N3d3hPSjFod1NBLU04eGtfM1pSdl90Znh5bE82bnFYQkZzeG5YSllUdzU4bmFrVWxUMlBCSE9XUXBQNDY5aGhUYjFyZGE4UXBxcWtDd3dnWno1SnVBVkhIUEU2bWhLWDRINDBNMlBpV1hfQ0ZKX2dIU0E?oc=5 · headline: Boulevard Bio launches with Deerfield backing for IgAN pipeline · publication: AllScigoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMingFBVV95cUxOc05vOXFkbHdvOWRzcnlxQnZtY3pyYWVTbks1dGhnVkM0eVE1bDZtaEU0MlVoSngzUXNBVmFmbUI4NU1jM2V5RF9qbTZjeTNVWGNvamNNMUM4RXNrN19oRWI1eGU5MV92M3l5cXlXN2Q2TUJ1eXk3M1lvZ216Yi02VVdLdENEQ2Q4Sk40azBWV3B5d2c1SjZXY001alpuUQ?oc=5 · headline: Boulevard Bio dreams big in immunology with $65M, sights on Vera’s IgAN drug · publication: Endpoints Newsgoogle_news · 8/15/2026